The
The anti-apoptotic protein Bcl-2 regulates a distal step in an evolutionarily conserved pathway for cell death (1) (2) (3) (4) . Overproduction of Bcl-2 occurs frequently in human cancers and contributes to tumor radio-and chemoresistance by blocking apoptosis induced by genotoxic injury and other types of damage (5) . Conversely, reduced levels of Bcl-2 have been associated with higher rates of spontaneous and inducible apoptosis in circulating lymphocytes of persons infected with HIV and some other viruses (6, 7) .
The Bcl-2 protein shares no significant amino acid sequence homology with other proteins for which a biochemical mechanism is known. To gain insights into the function of the Bcl-2 protein therefore we recently attempted to identify proteins with which Bcl-2 physically interacts, thus leading to the discovery of a protein BAG-1 that binds to Bcl-2 in vitro and that enhances the anti-apoptotic activity of Bcl-2 in cotransfection assays (8) . Like BAG-1, the serine/threonine protein kinase Raf-1 can cooperate with Bcl-2 in suppressing apoptosis, based on cotransfection assays using Bcl-2 and a transforming version of Raf-1 consisting only of the catalytic domain devoid of its N-terminal negative-regulatory domain and Ras-binding site (9) . Furthermore, full-length Raf-1 protein, as well as Raf-1 deletion mutants containing only the catalytic domain, can be coimmunoprecipitated with Bcl-2 from mammalian cells and from Sf9 insect cells when infected with recombinant Bcl-2 and Raf-1 baculoviruses. However, Raf-1 may not directly bind to Bcl-2 and indeed does not induce phosphorylation of the Bcl-2 protein in vitro or in cells (9) .
An N-terminal domain in Bcl-2 that is conserved among the anti-apoptotic members of the Bcl-2 protein family (termed A-box or BH4 domain) is required for its association with BAG-1 and Raf-1 in vitro (unpublished data). The pro-apoptotic Bcl-2 family protein Bax lacks this domain and fails to interact with either BAG-1 or Raf-1 in vitro. We therefore asked whether BAG-1 might bind to Raf-1. Our findings indicate that BAG-1 not only binds to Raf-1 but can also activate this kinase, suggesting that BAG-i represents a novel type of Raf-1 activating protein.
MATERIALS AND METHODS Coimmunoprecipitation Assays. Sf9 cells (6 x 106) were coinfected with BAG-i and either Raf-1 or ,3-galactosidase (13-gal) recombinant baculoviruses (multiplicity of infection -10). Cells were lysed after 60 hr in 0.65 ml of Nonidet P-40 (NP-40) lysis buffer (10 mM Hepes, pH 7.5/142.5 mM KCI/5 mM MgCl2/1 mM EGTA/0.2% NP-40) containing 1 mM phenylmethylsulfonyl fluoride (PMSF), 5 ,tg/ml leupeptin, and 5 ,ug/ml aprotinin. After preclearing with normal rabbit antiserum (50 ,ul/ml) and 50 ,ul protein A-Sepharose at 4°C for 1 hr, immunoprecipitations were performed by incubating 0.2 ml of lysate with 20 ,ul of protein A-Sepharose preadsorbed with 10 ,ul of anti-Raf-1 antiserum (10), anti-BAG-i antiserum (8) , or normal rabbit antiserum as a negative control at 4°C for 3 hr. After extensive washing in NP-40 lysis buffer, beads were boiled in 60 ,ll of Laemmli buffer and 20 ,ll of the eluted proteins were subjected to SDS/12% PAGE immunoblot analysis using 0.2% (vol/vol) anti-Raf-1 monoclonal antibody ascites (URP30) (lanes 1-3) or anti-,3-gal monoclonal antibody (Santa Cruz Biotechnology), followed by 0.3 ,ug/ml HRPasegoat anti-mouse (Bio-Rad), and detected using an enhanced chemiluminescence system (Amersham).
Cos-7 cells (1 x 106) in 10 ml of DMEM containing 10% fetal calf serum were transiently transfected with 20 ,ug of pcDNA3-HA-BAG-1 or pcDNA3 parental vector with 20 ,g of pKRSPA-BXB(Raf-1) or pKRSPA parental plasmid DNA by a calcium-phosphate precipitation method. Cells were lysed 60 hr later in 0.35 ml of NP-40 lysis buffer and incubated at 4°C for 3 hr with 20 ,ul of protein G-Sepharose preadsorbed with 3 ,ug of anti-HA (hemagglutinin) mouse monoclonal antibody (12CA5, Boehringer Mannheim). After washing 3 times in 1.5 ml of NP-40 lysis buffer, immune complexes were subjected to SDS/4-20% PAGE immunoblot analysis using anti-Raf-1 rabbit antiserum or anti-BAG-i rabbit antiserum, followed by HRPase-goat anti-rabbit (Bio-Rad) and detection by enhanced chemiluminescence.
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dium that contained glucose or galactose for repression or activation, respectively, of the Gall promoter in pJG4-5 was scored 4 days later, as described (11, 12 The 293 cells were transfected with 20 ,ug of pcDNA3-HA-BAG-1, pcDNA3-HA-BAG-l(AN), or pcDNA3 parental plasmid DNA by a CaPO4 precipitation method and selected in 800 ,ug/ml G418. Clones expressing high levels of HA-BAG-1 proteins were isolated and 107 transfected cells were lysed in NP-40 lysis buffer or RIPA buffer containing 1 mM sodium orthovanadate, 5 mM NaF, 1 mM PMSF, 5 ,ug/ml leupeptin, and 5 ,ug/ml aprotinin. Endogenous Raf-1 protein was immunoprecipitated with protein A-Sepharose preadsorbed with anti-Raf-1 rabbit antiserum and in vitro kinase assays were performed using 1 ,ug of GST-MEK as a substrate (13) .
Assay for Raf-I Activation in Yeast. Saccharomyces cerevisiae strain SY1984-RP was used to detect effects of BAG-1 on Raf-1 activity, essentially as described (14) . SY1984-RP cells were transformed with pAAH5-BAG-1, pAD4-Bcl-2, pAD4-SOD, YEplacl8l-Mas7OP, pAAH5 empty vector, YEpl3 parental vector, or YEpl3-RAS1 plasmid DNA. Activation of Raf-1 was detected by growth on histidine-deficient SC-plates for 3 days, indicating activation of the FUS1::HIS3 reporter gene.
RESULTS
For initial experiments, Raf-1 and BAG-1 were coexpressed in Sf9 insect cells using recombinant baculoviruses. Immunoprecipitations were performed using antisera specific for Raf-1 and BAG-1, or with normal rabbit serum as a control, followed by SDS/PAGE immunoblot assay using anti-Raf-1 antibodies. Under these conditions -5% of the total Raf-1 coimmunoprecipitated with BAG-1 ( Fig. 1A ) and vice versa (not shown). The association of Raf-1 with the BAG-1 protein was specific, since in Sf9 cells coinfected with a (3-gal-and a BAG-1-producing virus, X3-gal protein failed to coimmunoprecipitate with BAG-1 (Fig. 1A) .
The domain within the Raf-1 protein required for its association with BAG-1 was mapped using recombinant baculoviruses encoding GST-fusion proteins that contained: (i) fulllength Raf-1, (ii) a mutant consisting essentially only of the catalytic domain [Raf-BXB], and (iii) a mutant lacking the catalytic domain [Raf-GRS] (Fig. 1B) . Sf9 cells were coinfected with a BAG-1 virus and one of these GST-Raf-1-producing viruses. GST-fusion proteins were then recovered on glutathione-Sepharose and associated BAG-1 was detected by SDS/PAGE immunoblot assay, revealing that BAG-1 specifically associated with full-length Raf-1 and the Raf-l(BXB) protein, which consists essentially only of the catalytic domain, but not with the Raf-l(GRS) mutant that lacks the catalytic domain of Raf-1 (Fig. 1B) . Incubating the blot with an anti-GST monoclonal antibody however confirmed production of the GST-Raf-l(GRS) protein, excluding problems with expression of the GST-Raf-l(GRS) protein as an explanation for its failure to associate with BAG-1 in Sf9 cells. The catalytic domain of Raf-1 therefore appears to be sufficient for interactions with BAG-1, similar to our previous studies where the domains in Raf-1 required for coimmunoprecipitation with Bcl-2 were mapped (9) .
To confirm that association of BAG-1 and Raf-1 can occur in mammalian cells, Cos-7 cells were transiently cotransfected with expression plasmids producing an HA-tagged BAG-1 protein and the catalytic domain of Raf-l(BXB). Immunoprecipitates were prepared using anti-HA antibody and subjected to SDS/PAGE immunoblot assays using anti-Raf-1 or anti-BAG-1 antibodies, revealing that Raf(BXB) protein can coimmunoprecipitate with HA-Bag-1 (Fig. 1C) . Endogenous full-length p72-74 Raf-1 could also be coimmunoprecipitated with HA-BAG-1 from 293 cells, though the signals were more difficult to see because of the relative low levels of Raf-1 in these cells (not shown). The proportion of Raf-l(BXB) associated with BAG-1 represented -1% of the total cellular amount of this protein (Fig. 1A) .
The only region in the BAG-1 protein that shares significant amino acid homology to other known proteins is a ubiquitinlike domain located between residues 43 and 89. To explore whether binding of BAG-1 to Raf-1 requires this domain, an N-terminal deletion mutant of BAG-1 that lacks the first 89 amino acids was expressed in bacteria as a GST-fusion protein and compared with full-length GST-BAG-1 for ability to interact in vitro with in vitro translated 35S-Raf-1 protein. The full-length BAG-1 and BAG-1(AN) GST-fusion proteins bound to Raf-1 with comparable efficiencies (Fig. 1D) , indicating that the ubiquitin-like domain of BAG-1 is not required for its interaction with Raf-1 and demonstrating that residues 90 -> C terminus of BAG-1 are sufficient for binding to Raf-1. This experiment also complements the above studies where Raf-1 and BAG-1 were expressed in mammalian or insect cells, showing that bacterially-produced BAG-1 can bind in vitro to Raf-1 produced in reticulocyte lysates. The failure of GST-BAG-1 to bind to in vitro translated R-Ras protein, as well as the lack of binding of in vitro translated Raf-1 with GST-CD40 and GST-TNFRI confirmed the specificity of these protein interactions (Fig. 1D) .
Evidence has been obtained that the enzymatic activity of Raf-1 can be increased through interactions with other proteins, including some members of the Ras and 14-3-3 protein families, though these protein-protein interactions are probably insufficient by themselves for fully activating the kinase (14) (15) (16) (17) (18) (19) (20) . Like BAG-1, 14-3-3 family proteins can interact with Raf-1 at least in part through binding to its catalytic domain (CR3), whereas Ras proteins bind by means of a domain (CR1) located in the N-terminal portion of Raf-1 (14) (15) (16) (17) (18) (19) (20) . We therefore tested whether bacterially-produced GST-BAG-1 protein could influence the enzymatic activity of Raf-1. For these experiments, full-length Raf-1 was immunoprecipitated from Sf9 cells that had been infected with a Raf-1 baculovirus and the resulting immune complexes were incubated in vitro with 1 Ag of a physiological Raf-1 substrate (bacteriallyproduced, affinity-purified GST-MEK) and various amounts of purified GST-BAG-1 or control GST proteins. GST-BAG-1, but not control GST, increased the specific activity of Raf-l as measured by phosphorylation in vitro of GST-MEK (Fig. 2A) . The BAG-1-mediated increase in the kinase activity of Raf-1 was linear up to -5 ,ug of GST-BAG-1 protein, after which addition of more GST-BAG-1 protein had either no effect or began to exert inhibitory effects, possibly because of interference with Raf-1 access to GST-MEK substrate. An -5-fold elevation in the specific activity of Raf-1 was induced by 5 ,ug GST-BAG-1, after correcting for any nonspecific effects of the GST control protein. BAG-1 did not directly phosphorylate the GST-MEK substrate, based on experiments where GST-BAG-1 was incubated with GST-MEK in the presence of [,y-32P]ATP or where GST-BAG-1 was added to immune complexes that had been prepared from Sf9 cells infected with a (3-gal baculovirus instead of Raf-1 virus (Fig.  2B and not shown ). An His6-tagged, affinity-purified BAG-1 protein activated Raf-1 in vitro to a similar extent as GST-BAG-1 (-3.5-fold increase), implying that the GST moiety is unimportant for this effect (Fig. 2B, lane 1) . The GST-BAG-1(AN) protein also activated Raf-1 in vitro, almost as efficiently as full-length GST-BAG-1 protein (-3-fold) (Fig. 2B, lane 3) . Various GST control proteins, including GST, GST-Bcl-2, and GST-Bax, did not induce elevations in Raf-1 activity above their baseline levels (Fig. 2B, lanes 4 and 5, and not shown) .
Though Raf-1 bound to BAG-1 in vitro, it did not induce phosphorylation of BAG-1 protein. For example, experiments were performed in which GST-BAG-1 protein or GST-MEK as a positive control were incubated with Raf-1(259D), a transforming constitutively active form of Raf-1. The Raf-1(259D) protein induced no detectable phosphorylation of BAG-1, whereas GST-MEK was heavily phosphorylated (Fig.  2C, lanes 2 and 4) . Use of another mutant of Raf-1 that lacks enzymatic activity, Raf-1 (YY340, 341FF), served as a negative control (lanes 1 and 3) (21, 22) . Raf-1 also did not induce detectable phosphorylation of BAG-1 in 32PO4-labeled Sf9 cells (not shown). Thus, Raf-1 fails to phosphorylate both BAG-1 and Bcl-2 ( Fig. 2C) (9) , though it can be coimmunoprecipitated with these proteins.
To gain insights into whether BAG-1 can activate Raf-1 in mammalian cells, expression plasmids producing BAG-1 or BAG-1(AN) protein were stably transfected into 293 cells and Raf-1 was immunoprecipitated under conditions of gentle detergent (0.2% NP-40) designed to preserve protein-protein interactions or using harsh detergent (RIPA buffer) conditions that disrupt most protein-protein interactions. When using gentle conditions, Raf-1 immunoprecipitated from BAG-1 and BAG-1(AN) expressing cells had 2-2.5 higher specific activity than when immunoprecipitated from control transfected cells under the same the conditions. In contrast, when Raf-1 immunoprecipitates were prepared using harsh conditions, no differences were noted in the activity of Raf-1 from the control-transfected and the BAG-1-or BAG-1(AN)-transfected 293 cells. Immunoblot analysis of immune complexes prepared under the same conditions revealed similar amounts of Raf-1 protein for all samples and demonstrated that BAG-1/Raf-1 interactions were preserved in 0.2% but not in RIPA buffer (not shown). These findings therefore suggest that for BAG-1 to stimulate increases in Raf-1 activity, it or an associated protein must be bound to Raf-1.
Because the experiments described above did not involve use of purified Raf-1 protein, we cannot determine whether BAG-1 directly binds to and activates this kinase. However, Raf-1 also displayed specific interactions with Bag-1 in yeast two-hybrid experiments (Fig. 3A) , implying either that these two proteins directly bind to each other or that other required proteins are conserved even in budding yeast. As expected, BAG-1 also interacted with Bcl-2 in these two-hybrid assays, but not with Ha-Ras (V12), Bax, or Fas (Fig. 3A and data not  shown) . Moreover, BAG-1 also activated mammalian Raf-1 in budding yeast (Fig. 3B) , based on experiments using the same reporter gene system that has been employed previously to document activation of Raf-1 by Ras and 14-3-3 proteins (14) . Raf-1-dependent activation of the FUS1/HIS3 reporter gene was monitored by growth of five independent transformants on histidine-deficient medium for 3 days (14) . and 14-3-3. The region within BAG-1 that is sufficient for binding to and activating Raf-1 (amino acid 90 -> C terminus), however, is predicted to contain several a-helical regions, and to that extent has some similarity with 14-3-3 proteins (23, 24) . Because BAG-1 specifically binds to the catalytic domain of Raf-1, presumably the mechanism by which it induces activation of this kinase is more similar to 14-3-3 proteins that can also bind with at least weak affinity to the catalytic domain of Raf-1, than Ras proteins that interact with a domain in the N-terminal regulatory region of this protein kinase (14) (15) (16) (17) (18) (19) (20) . Although we can only speculate as to how the interaction of BAG-1 with Raf-1 promotes activation of the kinase, conceivably BAG-1 may dislodge the negative regulatory domain of Raf-1 from its catalytic domain, stabilize the kinase in an active conformation once activated by other mechanisms, or protect Raf-1 from inactivation by phosphatases (25) (26) (27) . Alternatively, BAG-1 may recruit other proteins to Raf-1 that are directly responsible for activating the kinase. Given that BAG-1 also activated Raf-1 in yeast, however, its seems more likely that BAG-1 directly activates Raf-1, but we cannot exclude the possibility that the cellular machinery required for BAG-1-mediated activation of Raf-1 is well conserved throughout evolution or that Raf-1 activation is a (at least) two-step process with BAG-1 fulfilling one of the necessary requirements for activation of Raf-1 in yeast and other evolutionarily conserved proteins playing an essential role as well. In this regard, our previous demonstration that Bcl-2 and Raf-1 can be coimmunoprecipitated from Sf9 cells coinfected with Raf-1 and Bcl-2 baculoviruses implies that either Sf9 cells or baculovirus may encode a homolog of BAG-1 that facilitates interactions of Raf-1 with Bcl-2 (9). Finally, by analogy to Ras that may activate Raf-1 at least in part by targeting it to membranes, it is conceivable that BAG-1 may promote Raf-1 activation by pulling Raf-1 into the vicinity of intracellular membranes through its interactions with integral membrane proteins such as Bcl-2 (28, 29) .
The finding that BAG-1 can bind to and activate Raf-1 raises the possibility that Raf-1 may become activated locally in the vicinity of Bcl-2 though a protein-protein interaction mechanism, thus potentially targeting Raf-1 to unique substrates presumably involved in the regulation of apoptosis as opposed to the mitogen-activated protein kinase-signaling pathway in which Raf-1 has traditionally been implicated. In this regard, we have obtained evidence that BAG-1, Raf-1, and Bcl-2 can form trimolecular complexes, but their stoichiometry appears to be low (1i%), suggesting that only a small proportion of the total cellular Raf-1 may be found in such complexes (unpublished observations). Consistent with this idea, however, targeting of the kinase domain of Rafl[Raf-BXB] to mitochondrial membranes using the transmembrane domain of the yeast outer mitochondrial membrane protein Mas-p70 markedly increases its anti-apoptotic effects in a hemopoietic cell line in which withdrawal of lymphokines results in programmed cell death (data not shown). Given that Bcl-2 is located primarily in the membranes of the mitochondria, nuclear envelope and parts of the endoplasmic reticulum (30), presumably whatever substrates to which Bcl-2/BAG-1 complexes might target Raf-1 would be different at least in part from those associated with the plasma membrane where Raf-1 participates in growth factor receptor signal transduction. Candidates for such substrates that have been hypothesized as potentially explaining the anti-apoptotic actions of Bcl-2 include antioxidant enzymes, Ca2+ transporters, and members of the ced-3 family of proteases or their regulators (reviewed in ref. 1) .
The kinase inhibitor staurosporine has been reported to induce apoptosis in a wide variety of types of cells at concentrations typically of .1-10 ,tM, implying that inhibition of certain kinases is a stimulus for apoptosis. Overexpression of Bcl-2 however protects cells from staurosporine-induced apoptosis (8, 31) , implying that Bcl-2 does not require a staurosporine-sensitive kinase for its death-suppressing function. Though staurosporine has been reported to completely inhibit the activity of purified protein kinase C in vitro at 10 nM (32), we observed that the activity of Raf-1 was entirely unaffected by -5 ,tM of staurosporine and only 20% inhibition was produced by 20 ,uM (data not shown). Raf-1 therefore is a staurosporine-resistant kinase, consistent with the possibility that antiapoptotic function of Bcl-2 may be at least in part dependent on Raf-1. It remains to be determined whether the interaction of BAG-1 with Raf-1 is essential for suppression of apoptosis.
